BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 21434877)

  • 1. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
    J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
    Chiang HL; Lyu RK; Tseng MY; Chang KH; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
    Clin Chim Acta; 2009 Jul; 405(1-2):143-7. PubMed ID: 19410571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.
    Jin T; Hu LS; Chang M; Wu J; Winblad B; Zhu J
    Eur J Neurol; 2007 May; 14(5):563-8. PubMed ID: 17437617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Puta E; Naldi P; Castello L; Monaco F; Avanzi GC
    J Neurol Sci; 2008 Jun; 269(1-2):138-42. PubMed ID: 18279894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Pashenkov M; Jin JP; Link H
    J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barré syndrome revealed by proteomics analysis.
    Chang KH; Lyu RK; Tseng MY; Ro LS; Wu YR; Chang HS; Hsu WC; Kuo HC; Huang CC; Chu CC; Hsieh SY; Chen CM
    Proteomics Clin Appl; 2007 May; 1(5):467-75. PubMed ID: 21136698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barré syndrome.
    Gonzalez-Quevedo A; Carriera RF; O'Farrill ZL; Luis IS; Becquer RM; Luis Gonzalez RS
    Neurol India; 2009; 57(3):288-94. PubMed ID: 19587469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
    Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
    Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
    Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
    Front Immunol; 2019; 10():515. PubMed ID: 30984164
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy.
    Huang YC; Lyu RK; Tseng MY; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
    J Neuroimmunol; 2009 Jan; 206(1-2):100-5. PubMed ID: 19049845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chi LJ; Xu WH; Zhang ZW; Huang HT; Zhang LM; Zhou J
    J Peripher Nerv Syst; 2010 Dec; 15(4):345-56. PubMed ID: 21199106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    McCombe PA; Csurhes PA; Greer JM
    J Neuroimmunol; 2006 Nov; 180(1-2):172-7. PubMed ID: 16935351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.